Drug and alcohol review最新文献

{"title":"‘It's Hard to Look Past the Accessibility’: Service Provider Perspectives on Implementing Telehealth for Alcohol and Other Drug Counselling as a Health Service Innovation","authors":"Ashlea Bartram,&nbsp;Md Abdul Ahad,&nbsp;April Long,&nbsp;Dan I. Lubman,&nbsp;Ele Morrison,&nbsp;Jill Rundle,&nbsp;Nicole Lee,&nbsp;Scott Wilson,&nbsp;Jacqueline Bowden","doi":"10.1111/dar.70000","DOIUrl":"https://doi.org/10.1111/dar.70000","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Offering telehealth services is an opportunity to reduce barriers to accessing and attending face-to-face alcohol and other drug (AOD) treatment. However, little is known about how telehealth options have been implemented by AOD services.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Key informant interviews were conducted with 20 senior staff members from government and non-government AOD treatment services in Australia with current or previous experience in delivering AOD counselling face-to-face and via phone and/or video, and thematically analysed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Interviewees described implementing telehealth flexibly alongside face-to-face counselling, with choice of mode shaped by client needs and preferences. Telehealth was valued for increasing the service's ability to reach under-served clients and for allowing clients to access services from a place of psychological safety. However, service providers were less certain about the comparative safety and effectiveness of delivering counselling through telehealth, especially when delivered over the phone. Telehealth was viewed as relatively compatible with current processes for face-to-face delivery, including processes for staff skill development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Telehealth has been implemented alongside face-to-face counselling to increase access and meet client preferences. Further evidence regarding risk assessment and client outcomes via phone and video is needed to support broader diffusion of this innovation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1321-1329"},"PeriodicalIF":3.0,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70000","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"‘You Can Sort of Justify Having That Drink’: Australian Young Adults' Perspectives on the Appeal and Influence of ‘Better for You’ Alcohol Products","authors":"Ashleigh Haynes,&nbsp;Anna Denejkina,&nbsp;Madelyn Sands,&nbsp;Pamela Wong,&nbsp;Zenobia Talati,&nbsp;Danica Keric,&nbsp;Julia Stafford,&nbsp;Ainslie Sartori,&nbsp;Gael Myers,&nbsp;Jane Martin,&nbsp;Tahnee McCausland,&nbsp;Melanie Wakefield,&nbsp;Helen Dixon","doi":"10.1111/dar.70001","DOIUrl":"https://doi.org/10.1111/dar.70001","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol industry publications reveal that the industry targets young people with better for you (BFY) marketing that promotes the nutrition and health-oriented aspects of some products, despite the inherent harms of alcohol consumption. This research investigated how young adults conceptualise the appeal of BFY alcohol products and their potential effect on consumption, and their opinions of the alcohol industry in the context of this marketing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Six online semi-structured focus groups stratified by gender and alcohol consumption frequency were conducted with <i>N</i> = 27 West Australians aged 18–24 years who drank alcohol in the past year. Data were interpreted using thematic analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>BFY alcohol products are seen by young adults as healthier options and thus justify greater alcohol consumption by offering a way to actively manage health risks. However, BFY products were also appealing in ways that aligned with more traditional alcohol marketing and with reasons for drinking (e.g., by enhancing enjoyment, pleasure and self-presentation). While there was some cynicism and criticism of the alcohol industry for BFY marketing which was viewed as misleading, some young adults were appreciative as they saw it as providing information to help them make informed choices.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>To reduce alcohol use among young adults, counter-marketing that harnesses critical reflection and cynicism towards the alcohol industry or draws attention to the misleading nature of BFY claims may be a useful strategy. Ultimately, regulatory changes to restrict alcohol marketing that serves to mislead consumers by positioning some alcohol products as healthier options is needed.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1573-1580"},"PeriodicalIF":3.0,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychological Distress Trajectories in Residential Alcohol and Other Drug Treatment","authors":"Emma L. Hatton,&nbsp;Peter J. Kelly,&nbsp;Laura Robinson,&nbsp;Alison Beck,&nbsp;Mei L. Lee,&nbsp;Robert Stirling,&nbsp;Lauren Mullaney,&nbsp;Michele Campbell,&nbsp;Briony Larance","doi":"10.1111/dar.14099","DOIUrl":"10.1111/dar.14099","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Residential clients frequently report high psychological distress at intake, but little is known about changes in distress throughout treatment. This study aimed to identify in-treatment trajectories for psychological distress and factors associated with trajectory classes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective cohort of adults attending Australian non-government residential substance use treatment between 2012 and 2023 was identified from routinely collected data, NADAbase. Participants (<i>N</i> = 1492) completed ≥ 3 Kessler-10 Psychological Distress Scale (K10) assessments within 90 days of intake. Latent growth curve analyses identified classes of K10 trajectories. Multinomial regression identified demographic and clinical correlates (Severity of Dependence Scale [SDS] and EUROHIS Quality of Life scale [EQoL-8]) of class membership.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A five-class model describing K10 trajectories (1: moderate–low improved; 2: high–low improved; 3: very high–moderate improved; 4: very high–high improved; 5: very high unchanged) had the best model fit. Compared to high–low improved (34.5%; referent), moderate–low improved (45.4%) were less likely to identify as female, have higher SDS and lower EQoL-8 scores, or use cannabis; very high–moderate improved (13.1%) were more likely to have lower SDS scores, be aged under 25 and use opioids; very high–high improved (5.6%) were less likely to identify as male, be aged over 25, have higher EQoL and SDS scores; and very high unchanged (1.3%) were more likely to have lower EQoL scores and have left without completing treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Four K10 trajectory classes showed improvement after 90 days. Around 7% reported sustained high to very high psychological distress. Routine monitoring of psychological distress provides opportunities to identify non-improving clients and review treatment plans to improve outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1308-1320"},"PeriodicalIF":3.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.14099","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144316173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vaping cessation strategies and triggers for relapse amongst people from New Zealand who have vaped","authors":"Mehdi Rahimi,&nbsp;Bodo Lang,&nbsp;Lion Shahab,&nbsp;Jamie Brown,&nbsp;Amanda Palmer,&nbsp;Joya Kemper,&nbsp;Chris Bullen,&nbsp;George Laking,&nbsp;Vili Nosa,&nbsp;Varsha Parag,&nbsp;Natalie Walker","doi":"10.1111/dar.14061","DOIUrl":"10.1111/dar.14061","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>In New Zealand (NZ) vapes (e-cigarettes) are a government-endorsed strategy to help people stop smoking, as well as being used recreationally by people who have never smoked. Nicotine vapes are addictive and many users want to quit. We surveyed current and past users of nicotine vapes to gather insights about their vaping cessation reasons and strategies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In December 2022, we undertook a web-based survey in NZ using market research survey panels. Eligible panellists were aged ≥16 years, did not currently smoke and had vaped nicotine. Questions focused on demographics, smoking and vaping status, vaping dependence, strategies used to quit vaping, and triggers for vaping relapse.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>One thousand one hundred nineteen participants completed the survey: 144 had never smoked; 975 used to smoke, 401 currently vaped nicotine, and 718 used to vape nicotine. Participants were predominantly aged ≥25 years (89%); 63% were female, and 21% were Indigenous Māori and/or Pacific. Predictors of vaping dependence were having smoked or vaped for ≥2 years and vaping &gt;3% nicotine. Reasons for trying to quit vaping included health concerns, disliking feeling dependent, and cost. Quitting strategies included stopping abruptly, nicotine tapering and family/friend support. Triggers for relapse were stress, being around others who vaped and nicotine withdrawal.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusion</h3>\u0000 \u0000 <p>In NZ reasons to quit and triggers to return to vaping are similar to quitting smoking. Until more research is available, it seems appropriate to support people who wish to stop vaping with similar strategies used to support people to quit smoking.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1394-1411"},"PeriodicalIF":3.0,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.14061","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in Drug-Induced Hospitalisations and Deaths During the First Year of the COVID-19 Pandemic in Australia","authors":"Nicola Man,&nbsp;Jane Akhurst,&nbsp;Olivia Price,&nbsp;Agata Chrzanowska,&nbsp;Rachel Sutherland,&nbsp;Paul M. Dietze,&nbsp;Raimondo Bruno,&nbsp;Louisa Degenhardt,&nbsp;Wing See Yuen,&nbsp;Lauren Moran,&nbsp;Louise Tierney,&nbsp;Amy Peacock","doi":"10.1111/dar.14088","DOIUrl":"10.1111/dar.14088","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>We aimed to determine whether the trend in the rate of drug-induced hospitalisations and deaths changed during the first year of the COVID-19 pandemic in Australia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data comprised crude monthly rates (per 1,000,000 persons) of hospitalisations and deaths directly attributable to illicit drugs, prescription medicines, or medicines available without a prescription, nationally from 2011 to 2021. Observed rates during the COVID-19 pandemic (2020–2021) were compared with their counterfactual forecast in an ARIMA model, overall and disaggregated by sex, age and drug involved.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Observed rates of drug-induced hospitalisation and death, overall and by sex, were not significantly different from the forecasted rates. The rates of drug-induced death among people aged 35–54 and 55+ years were lower than forecasted by 2.1 [95% prediction interval = −3.8, −0.4] and 0.7 [−1.3, −0.1] deaths per 1,000,000 persons per month, respectively. The rates of drug-induced hospitalisation and death involving heroin were lower than forecasted by 1.5 [−2.4, −0.7] and 1.0 [−1.3, −0.6] per 1,000,000 persons per month, respectively, as were those involving amphetamine-type stimulants by 12.4 [−21.4, −0.8] and 0.5 [−0.7, −0.2] per 1,000,000 persons per month, respectively. The rate of cannabinoid-induced hospitalisations was higher than forecasted by 3.8 [0.8, 6.8] hospitalisations per 1,000,000 persons per month.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>We found no evidence of an overall difference in the rate of drug-induced harms during the COVID-19 pandemic relative to the forecasted trend. However, there were differences by drug involved, which may be explained by drug market disruptions and changes in drug use during the pandemic.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1419-1429"},"PeriodicalIF":3.0,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.14088","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Relationships Between Motives for Cannabis and Cannabidiol Use in People Who Co-Use: Results From the European Web Survey on Drugs.","authors":"Davide Fortin, Vincent Leroy, Patrizia Carrieri, João Matias, Tangui Barré","doi":"10.1111/dar.14090","DOIUrl":"https://doi.org/10.1111/dar.14090","url":null,"abstract":"<p><strong>Introduction: </strong>Cannabis is one of the most commonly used psychoactive substances globally. Cannabidiol (CBD) is a non-intoxicating cannabis compound increasingly used for various purposes, especially among cannabis users. However, to date, there are no data on the relationships between cannabis and CBD motives. Understanding these relationships and characterising people who co-use cannabis and CBD by their motives can help adapt marketing policies and foster CBD-based harm reduction practices for people who use cannabis.</p><p><strong>Methods: </strong>We selected cannabis users from the third wave of the European Web Survey on Drugs conducted in 21 EU and 9 non-EU countries. Using a multilevel mixed-effects logistic regression model, we identified factors associated with CBD co-use. We computed Bonferroni-adjusted tetrachoric correlations between cannabis and CBD self-reported motives for use. We computed Spearman's correlations between the number of declared cannabis and CBD motives. We performed an ascending hierarchical classification to identify cannabis-CBD co-user profiles based on their cannabis and CBD motives.</p><p><strong>Results: </strong>The study sample comprised 35,789 participants (42.3% who co-used CBD). CBD use was associated with reporting cannabis therapeutic-oriented motives. The numbers of motives for cannabis and CBD use were correlated (ρ = 0.49, p < 0.001). Similar motives were highly correlated between substances. Cluster analysis revealed four different co-user profiles.</p><p><strong>Discussion and conclusions: </strong>Individuals who use both cannabis and CBD tend to do so for similar reasons. Considering the safe profile of CBD, further research should explore the potential harm-reduction role of partially substituting tetrahydrocannabinol-based products with CBD-based products among people who use cannabis.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"‘I Think That Is a Big Step From Here to There’: Exploring the Views of Service Providers About Delivering Drug- and Alcohol-Related Health Services to Aboriginal People in Rural New South Wales","authors":"Raechel Wallace,&nbsp;Simon Clay,&nbsp;Anthony Shakeshaft,&nbsp;Sara Farnbach","doi":"10.1111/dar.14096","DOIUrl":"10.1111/dar.14096","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The higher rates of alcohol and other drug (AOD)-related harms in rural compared to metropolitan areas demonstrate the need for consideration of rural AOD health service delivery. We aim to explore the experiences of health service providers around delivering AOD services to Aboriginal and Torres Strait Islander (hereafter, Aboriginal) people in rural New South Wales (NSW) and opportunities to optimise services.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Open-ended, semi-structured interviews or written responses were conducted with 18 Aboriginal and non-Aboriginal service providers at Aboriginal community-controlled health services, mainstream services or experts who work with Aboriginal people around AOD in rural NSW. Data were thematically analysed, led by an Aboriginal researcher.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Five themes were identified: (i) the role of family and community; (ii) the role of health services (particularly Aboriginal Community Controlled Health Services) in building cultural connections with clients; (iii) inconsistent referral and communication procedures impact the continuity of care; (iv) difficulties hiring, training and retaining Aboriginal workers; and (v) the role of technology in enhancing service access.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Key opportunities to improve the delivery of health service to Aboriginal people in rural NSW include programmes to drive culturally meaningful care, in both Aboriginal and non-Aboriginal services, systemic changes to increase access to AOD training among Aboriginal workers, and better remuneration. Shared clinical records and telehealth may enhance service delivery by increasing service access and referral processes; however, Aboriginal community leadership and cultural safety are crucial for safe design and delivery.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1564-1572"},"PeriodicalIF":3.0,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.14096","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing the Processes and Experiences of Using and Implementing a Routine Data Collection System at Two Aboriginal Alcohol and Other Drug Residential Services Located in Rural Queensland","authors":"Katinka van de Ven,&nbsp;Erin Cunningham,&nbsp;Phillip J. Tully,&nbsp;Alison Ritter","doi":"10.1111/dar.14095","DOIUrl":"10.1111/dar.14095","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Routine data collection in alcohol and other drug (AOD) treatment services is essential for continuous quality improvement, yet its implementation in Aboriginal residential services remains challenging. This study evaluates the processes and experiences of implementing a routine data collection system at two Aboriginal AOD residential rehabilitation services in rural Queensland, both of which operate under a family-centric model of care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A participatory evaluation approach was used, engaging staff and clients to co-design and implement data collection tools. The study progressed in two phases. Phase 1 focused on developing data collection tools. Phase 2 involved implementing these tools to assess client experiences and outcomes. Data collection included the Aboriginal Resilience and Recovery Questionnaire, WHOQOL-BREF and other validated AOD outcome measures, with surveys conducted at multiple time points.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Staff engagement was crucial to successful implementation, though maintaining involvement over time proved challenging. Logistical and financial barriers, including IT infrastructure limitations and staff turnover, impacted sustainability. Although post-treatment follow-up was difficult, many clients found the outcome survey to be a valuable therapeutic tool. The client experience survey led to direct service improvements, whereas outcome monitoring required additional refinement for long-term feasibility.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Routine data collection can enhance service quality and client outcomes when embedded into clinical practice. However, sustainability depends on staff buy-in, streamlined processes and dedicated resources. Addressing barriers to post-treatment follow-up and ensuring data collection remains relevant to both staff and clients will be essential for ongoing implementation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1556-1563"},"PeriodicalIF":3.0,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.14095","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analyses Updated to 2022–23 on Australian Attitudes Towards Supervised Injecting Facilities","authors":"Zachary Lloyd,&nbsp;Samantha Colledge-Frisby,&nbsp;Nicholas Taylor,&nbsp;Michael Livingston,&nbsp;Marianne Jauncey,&nbsp;Amanda Roxburgh","doi":"10.1111/dar.14089","DOIUrl":"10.1111/dar.14089","url":null,"abstract":"","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1444-1448"},"PeriodicalIF":3.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144224728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fentanyl Polysubstance Use Patterns and Their Associations With Hepatitis C Virus, Skin and Soft Tissue Infections, and Non-Fatal Overdose Among People Who Inject Drugs in New York City","authors":"Mehrdad Khezri,&nbsp;Sarah Kimball,&nbsp;Chenziheng Allen Weng,&nbsp;Courtney McKnight,&nbsp;Don Des Jarlais","doi":"10.1111/dar.14093","DOIUrl":"10.1111/dar.14093","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Fentanyl's euphoric effects and short half-life may increase infectious disease transmission risks through frequent injecting and syringe sharing. We examined fentanyl polysubstance use (PSU) patterns and associations with hepatitis C virus (HCV), skin and soft tissue infections (SSTI), and non-fatal overdose among people who inject drugs (PWID) in New York City.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We recruited 495 PWID between October 2021 and July 2024. Participants were tested for HCV antibody and underwent urine toxicology screenings using the Premier Biotech 13-panel BioCup.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fentanyl was identified in 83.6% of the sample; however, only 23.0% self-reported recent intentional fentanyl use. The most common fentanyl PSU combinations were fentanyl with methadone (67.9%), opiates (66.9%), cocaine (65.9%), cannabis (45.4%), xylazine (36.7%), heroin (35.5%), benzodiazepines (32.5%) and alcohol (29.3%). Compared to no fentanyl use, intentional fentanyl use was associated with HCV antibody seropositivity (aOR 3.44, 95% CI 1.75, 6.93), SSTIs (aOR 4.75, 1.66, 17.20) and non-fatal overdose (aOR 2.35, 1.15, 5.00). Co-use of fentanyl with opiates (aOR 2.08, 1.16, 3.82), cocaine (aOR 2.71, 1.52, 4.97), heroin (aOR 2.06, 1.11, 3.91), benzodiazepines (aOR 2.91, 1.55, 5.63) and alcohol (aOR 3.27, 1.72, 6.37) were associated with HCV. Co-use of fentanyl with benzodiazepines (aOR 2.08, 1.04, 4.34) and alcohol (aOR 2.57, 1.29, 5.37) were associated with non-fatal overdose.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>In addition to overdose, when combined with other psychoactive substances, fentanyl PSU is associated with a higher prevalence of infectious diseases. This underscores the need for tailored medication dosing for opioid use disorder and expanding access to syringe service programs and medical care for PWID in the fentanyl era.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 5","pages":"1543-1555"},"PeriodicalIF":3.0,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}